SCHEMBL30279429

SCHEMBL30279429

O=C1c2cc(Cl)cc(Cl)c2CCN1CC#CC1CC1

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ EZH2 Q15910 6/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23978794 0.79 — —
SCHEMBL23978802 0.76 SMN1; SMN2 (0.32) EZH2
SCHEMBL30279363 0.76 SMN1; SMN2 (0.32) EZH2
SCHEMBL2256507 0.59 MEN1 (0.52) —
SCHEMBL29844266 0.59 MEN1 (0.52) —
SCHEMBL10785645 0.59 MEN1 (0.37) —
SCHEMBL7815325 0.57 MEN1 (0.49) —
SCHEMBL28000654 0.57 MEN1 (0.49) —
SCHEMBL23978876 0.57 GRM5 (0.41) —
SCHEMBL30491508 0.56 IDH1 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4142707-A1 INHIBITORS OF ALPHA 2 BETA 1 INTEGRIN AND METHODS OF USE THEREOF The Regents of the University of California (US) 2023-03-08 — — EP disclosed
Send feedback